• Explore /
  • Poster
  • / A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.

A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.

Abstract Poster

Authors

Jian Campian

Jian Li Campian

Washington University School of Medicine in St. Louis, St. Louis, MO

Jian Li Campian , Jingqin Luo , Chai Avvaru , Ruth Katumba , Albert H Kim , Gavin P. Dunn , Christopher Abraham , Puspanjali Bhatta , Se Hwan Yang , Jean Fan , Byung Ha Lee , Sunita Ranjitka , Ngocdiep T. Le , George Ansstas , Tanner Michael Johanns , Milan G Chheda , Jiayi Huang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT03687957

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2040)

DOI

10.1200/JCO.2021.39.15_suppl.2040

Abstract #

2040

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Elma S. Hawkins

First Author: Matthias Holdhoff

First Author: Andrew E. Sloan

Poster

2016 ASCO Annual Meeting

A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).

A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).

First Author: Reena Parada Thomas